Remdesivir News and Research

RSS
Study identifies multiple pathways adopted by SARS-CoV-2 to develop resistance to nirmatrelvir

Study identifies multiple pathways adopted by SARS-CoV-2 to develop resistance to nirmatrelvir

11 Aug 2022
The features of the newly emerging SARS-CoV-2 Omicron BA.2.75 subvariant

The features of the newly emerging SARS-CoV-2 Omicron BA.2.75 subvariant

10 Aug 2022
The impact of cold agglutinin syndrome on clinical presentations in COVID-19

The impact of cold agglutinin syndrome on clinical presentations in COVID-19

8 Aug 2022
Researchers identify new therapies that could provide better protection against future COVID-19 variants

Researchers identify new therapies that could provide better protection against future COVID-19 variants

8 Aug 2022
Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

2 Aug 2022
Is cannabidiol effective against COVID-19?

Is cannabidiol effective against COVID-19?

31 Jul 2022
The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

The effects of CBD in the treatment of COVID-19–related inflammatory symptoms

28 Jul 2022
Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

26 Jul 2022
Tunneling nanotubes can assist SARS-CoV-2 propagation

Tunneling nanotubes can assist SARS-CoV-2 propagation

26 Jul 2022
Anti-SARS-CoV-2 nucleocapsid antibodies and pre-existing lung diseases may be independent predictors of long COVID

Anti-SARS-CoV-2 nucleocapsid antibodies and pre-existing lung diseases may be independent predictors of long COVID

21 Jul 2022
Scientists introduce SARS-CoV-2 phenotype screening for identifying novel antiviral drugs

Scientists introduce SARS-CoV-2 phenotype screening for identifying novel antiviral drugs

20 Jul 2022
Researchers report the detection of viral mutations associated with drug resistance in patients treated with REGEN-COV and sotrovimab

Researchers report the detection of viral mutations associated with drug resistance in patients treated with REGEN-COV and sotrovimab

20 Jul 2022
Should siRNA-based antivirals be added to the COVID toolbox?

Should siRNA-based antivirals be added to the COVID toolbox?

19 Jul 2022
Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

Nitazoxanide drug found to be a potent inhibitor of several human coronaviruses

18 Jul 2022
New approach could pave the way for development of pan-coronavirus antivirals

New approach could pave the way for development of pan-coronavirus antivirals

13 Jul 2022
The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients

The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients

13 Jul 2022
Does high-dose inhaled nitric oxide improve respiratory function and outcomes among pregnant patients hospitalized with severe COVID-19 pneumonia?

Does high-dose inhaled nitric oxide improve respiratory function and outcomes among pregnant patients hospitalized with severe COVID-19 pneumonia?

13 Jul 2022
Monoclonal antibody treatment taken by hospitalized COVID-19 patients reduces mortality

Monoclonal antibody treatment taken by hospitalized COVID-19 patients reduces mortality

8 Jul 2022
Study examines IMPACC trial results to understand clinical phenotypes of disease severity in hospitalized COVID-19 patients

Study examines IMPACC trial results to understand clinical phenotypes of disease severity in hospitalized COVID-19 patients

7 Jul 2022
Remdesivir resistance in renal transplant patients with long COVID-19

Remdesivir resistance in renal transplant patients with long COVID-19

1 Jul 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback